CO2020000774A2 - Rellenos de tejidos basados en ácido hialurónico de seda y métodos de utilizar los mismos - Google Patents
Rellenos de tejidos basados en ácido hialurónico de seda y métodos de utilizar los mismosInfo
- Publication number
- CO2020000774A2 CO2020000774A2 CONC2020/0000774A CO2020000774A CO2020000774A2 CO 2020000774 A2 CO2020000774 A2 CO 2020000774A2 CO 2020000774 A CO2020000774 A CO 2020000774A CO 2020000774 A2 CO2020000774 A2 CO 2020000774A2
- Authority
- CO
- Colombia
- Prior art keywords
- methods
- hyaluronic acid
- silk
- based tissue
- acid based
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 2
- 239000000945 filler Substances 0.000 title abstract 2
- 229920002674 hyaluronan Polymers 0.000 title abstract 2
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762525131P | 2017-06-26 | 2017-06-26 | |
| US201862641095P | 2018-03-09 | 2018-03-09 | |
| PCT/US2018/039574 WO2019005848A1 (en) | 2017-06-26 | 2018-06-26 | HYALURONIC SILK ACID TISSUE FILLING AGENTS AND METHODS OF USE THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2020000774A2 true CO2020000774A2 (es) | 2020-05-05 |
Family
ID=64742709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2020/0000774A CO2020000774A2 (es) | 2017-06-26 | 2020-01-23 | Rellenos de tejidos basados en ácido hialurónico de seda y métodos de utilizar los mismos |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP4169539B1 (https=) |
| JP (3) | JP2020525253A (https=) |
| KR (1) | KR20200032103A (https=) |
| CN (1) | CN111263646A (https=) |
| AU (2) | AU2018290810C1 (https=) |
| CA (1) | CA3068296A1 (https=) |
| CO (1) | CO2020000774A2 (https=) |
| ES (2) | ES2935887T3 (https=) |
| IL (2) | IL299584A (https=) |
| MA (1) | MA49520A (https=) |
| SG (1) | SG11201913229PA (https=) |
| UA (1) | UA127350C2 (https=) |
| WO (1) | WO2019005848A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230190997A1 (en) | 2017-06-26 | 2023-06-22 | Evolved By Nature, Inc. | Silk-hyaluronic acid based tissue filers and methods of using the same |
| JP6508431B1 (ja) | 2017-09-21 | 2019-05-08 | 住友電気工業株式会社 | 半絶縁性ヒ化ガリウム結晶基板 |
| AU2019405953B2 (en) * | 2018-12-19 | 2025-09-18 | Evolved By Nature, Inc. | Silk-hyaluronic acid tissue fillers and methods of making and using the same |
| US20220193305A1 (en) * | 2019-03-29 | 2022-06-23 | Trustees Of Tufts College | Crosslinked silk fibroin-based compositions, and methods of making and using the same |
| AU2020289479A1 (en) * | 2019-06-06 | 2022-02-03 | Evolved By Nature, Inc. | Silk stimulated collagen production and methods of use thereof |
| WO2020262596A1 (en) * | 2019-06-26 | 2020-12-30 | Compagnie Generale Des Etablissements Michelin | A noise improving tread |
| CN110339398A (zh) * | 2019-07-18 | 2019-10-18 | 王月玲 | 一种含氨基酸透明质酸钠注射剂及其制备方法 |
| EP4017537A4 (en) * | 2019-08-20 | 2023-08-16 | Evolved by Nature, Inc. | SILK PERSONAL CARE PRODUCTS |
| EP3995530B1 (en) * | 2019-09-27 | 2025-05-28 | LG Chem, Ltd. | A method of preparing polymer microparticles, polymer microparticles, medical composition, cosmetic composition, medical articles, and cosmetic articles using the same |
| PL4077402T3 (pl) * | 2019-12-19 | 2024-07-29 | Croma-Pharma Gmbh | Kwas hialuronowy modyfikowany tiolem i hydrożel zawierający usieciowany kwas hialuronowy |
| CN116507315A (zh) * | 2020-06-19 | 2023-07-28 | 自然进化公司 | 用于组织填充、组织间隔和组织膨胀的丝-透明质酸组合物 |
| US20250295691A1 (en) * | 2020-06-19 | 2025-09-25 | Evolved By Nature, Inc. | Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking |
| JP2024519426A (ja) * | 2020-09-29 | 2024-05-14 | ジロパ・インコーポレイテッド | 疼痛の緩和及び麻痺のための組成物及び方法 |
| TR202101065A1 (tr) * | 2021-01-25 | 2022-08-22 | Hacettepe Ueniversitesi | Hyaluroni̇k asi̇t jel i̇çeren bi̇r doku dolgu malzemesi̇ ve üreti̇m yöntemi̇ |
| CN114213517B (zh) * | 2021-02-08 | 2024-07-09 | 复向丝泰医疗科技(苏州)有限公司 | 利用切向流超滤技术制备可控高浓度丝素蛋白溶液的方法 |
| JP7695344B2 (ja) | 2021-05-21 | 2025-06-18 | ケンブリッジ クロップス インコーポレイテッド． ドゥーイングビジネスアズ モリ | 絹フィブロイン溶液及び絹フィブロインを含む粉末を製造するためのシステム及び方法 |
| WO2023275278A1 (en) * | 2021-06-30 | 2023-01-05 | Merz Pharma Gmbh & Co. Kgaa | Hyaluronic acid dermal fillers crosslinked with polyethylene glycol diglycidyl ether, method for making same and uses thereof |
| CN113368220A (zh) * | 2021-07-05 | 2021-09-10 | 云南维他源生物科技有限公司 | 一种ahco组合物及其制剂与应用 |
| KR20230013682A (ko) | 2021-07-16 | 2023-01-27 | 주식회사 휴메딕스 | Pegde로 가교된 히알루론산 필러 및 이의 제조방법 |
| US11864569B2 (en) | 2021-08-16 | 2024-01-09 | Cambridge Crops, Inc. | Systems and methods for improving the performance of cereal using a silk fibroin solution and powders containing silk fibroin |
| CN114028610B (zh) * | 2021-10-26 | 2022-10-25 | 北京诺康达医药科技股份有限公司 | 一种亲水性注射型皮肤填充组合物及其制备方法与应用 |
| KR102766244B1 (ko) * | 2024-02-16 | 2025-02-10 | 충남대학교 산학협력단 | Lc-ms/ms 기반의 히알루론산, bdde 및 bdde 가교된 히알루론산의 정량방법 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH453269A4 (https=) | 1968-03-29 | 1973-01-31 | ||
| FR2334107A1 (fr) | 1975-12-05 | 1977-07-01 | Pasteur Institut | Procede de couplage de substances biologiques par des liaisons covalentes |
| US4355023A (en) | 1980-09-30 | 1982-10-19 | The Massachusetts General Hospital | Antibody fragment compositions and process |
| US4657853A (en) | 1984-09-14 | 1987-04-14 | E. I. Du Pont De Nemours And Company | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US20060105022A1 (en) | 2004-11-15 | 2006-05-18 | Shiseido Co., Ltd. | Process for preparing crosslinked hyaluronic acid gel |
| US8357795B2 (en) * | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| US20110189292A1 (en) | 2009-04-20 | 2011-08-04 | Allergan, Inc. | Dermal fillers comprising silk fibroin hydrogels and uses thereof |
| WO2011059325A2 (en) * | 2009-11-11 | 2011-05-19 | University Of Twente, Institute For Biomedical Technology And Technical Medicine (Mira) | Dextran-hyaluronic acid based hydrogels |
| KR102238406B1 (ko) * | 2011-06-03 | 2021-04-08 | 알러간 인더스트리 에스에이에스 | 항산화제를 포함하는 피부 충전제 조성물 |
| CN108379112A (zh) * | 2011-09-14 | 2018-08-10 | 阿勒根公司 | 用于细纹治疗的真皮填充剂组合物 |
| CN102836465B (zh) * | 2012-08-30 | 2014-06-04 | 浙江星月生物科技股份有限公司 | 一种注射用丝素蛋白透明质酸复合凝胶及其制备与应用 |
| WO2014055895A1 (en) * | 2012-10-05 | 2014-04-10 | Allergan, Inc. | Injectable device and method for sculpting, augmenting or correcting facial features such as the chin |
| US20140315828A1 (en) * | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
| HK1224315A1 (zh) | 2013-06-28 | 2017-08-18 | Galderma S.A. | 用於制备交联的透明质酸产物的方法 |
| CA2925820C (en) * | 2013-09-30 | 2021-11-30 | Silk Therapeutics, Inc. | Silk protein fragment compositions and articles manufactured therefrom |
| EA035551B1 (ru) | 2014-12-02 | 2020-07-06 | Силк Терапьютикс, Инк. | Изделие |
| MX2017013949A (es) * | 2015-04-29 | 2018-11-09 | Silk Therapeutics Inc | Composiciones mectantes a base de seda y sus metodos. |
| US10175996B2 (en) | 2016-05-02 | 2019-01-08 | Norman R. Byrne | Information display and control for work areas |
| EP3503841A4 (en) * | 2016-08-24 | 2020-04-22 | Allergan, Inc. | CO-CROSSLINKED HYALURONIC ACID-FIBROIN HYDROGELS FOR IMPROVING THE SUSTAINABILITY OF TISSUE GRAFTS AND FOR INCREASING SOFT TISSUES |
-
2018
- 2018-06-26 AU AU2018290810A patent/AU2018290810C1/en active Active
- 2018-06-26 EP EP22197284.7A patent/EP4169539B1/en active Active
- 2018-06-26 SG SG11201913229PA patent/SG11201913229PA/en unknown
- 2018-06-26 CA CA3068296A patent/CA3068296A1/en active Pending
- 2018-06-26 JP JP2020520437A patent/JP2020525253A/ja active Pending
- 2018-06-26 IL IL299584A patent/IL299584A/en unknown
- 2018-06-26 WO PCT/US2018/039574 patent/WO2019005848A1/en not_active Ceased
- 2018-06-26 EP EP18823073.4A patent/EP3645063B1/en active Active
- 2018-06-26 CN CN201880055268.1A patent/CN111263646A/zh active Pending
- 2018-06-26 ES ES18823073T patent/ES2935887T3/es active Active
- 2018-06-26 ES ES22197284T patent/ES3018883T3/es active Active
- 2018-06-26 UA UAA202000401A patent/UA127350C2/uk unknown
- 2018-06-26 KR KR1020207002371A patent/KR20200032103A/ko not_active Ceased
- 2018-06-26 MA MA049520A patent/MA49520A/fr unknown
-
2019
- 2019-12-24 IL IL271692A patent/IL271692B2/en unknown
-
2020
- 2020-01-23 CO CONC2020/0000774A patent/CO2020000774A2/es unknown
-
2023
- 2023-07-28 JP JP2023122912A patent/JP7660619B2/ja active Active
-
2024
- 2024-09-10 AU AU2024219582A patent/AU2024219582A1/en active Pending
- 2024-11-01 JP JP2024192754A patent/JP2025020289A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020525253A (ja) | 2020-08-27 |
| EP4169539A1 (en) | 2023-04-26 |
| AU2024219582A1 (en) | 2024-10-03 |
| ES2935887T3 (es) | 2023-03-13 |
| AU2018290810C1 (en) | 2024-09-12 |
| US20230338614A1 (en) | 2023-10-26 |
| UA127350C2 (uk) | 2023-07-26 |
| JP2025020289A (ja) | 2025-02-12 |
| EP3645063A4 (en) | 2021-04-14 |
| EP4169539B1 (en) | 2025-01-29 |
| EP4169539C0 (en) | 2025-01-29 |
| JP2023139249A (ja) | 2023-10-03 |
| WO2019005848A1 (en) | 2019-01-03 |
| KR20200032103A (ko) | 2020-03-25 |
| AU2018290810B2 (en) | 2024-06-13 |
| JP7660619B2 (ja) | 2025-04-11 |
| EP3645063A1 (en) | 2020-05-06 |
| CN111263646A (zh) | 2020-06-09 |
| CA3068296A1 (en) | 2019-01-03 |
| IL299584A (en) | 2023-03-01 |
| SG11201913229PA (en) | 2020-01-30 |
| IL271692B2 (en) | 2023-06-01 |
| ES3018883T3 (en) | 2025-05-19 |
| IL271692A (en) | 2020-02-27 |
| EP3645063B1 (en) | 2022-09-28 |
| MA49520A (fr) | 2021-04-14 |
| AU2018290810A1 (en) | 2020-02-13 |
| BR112019027687A2 (pt) | 2020-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020000774A2 (es) | Rellenos de tejidos basados en ácido hialurónico de seda y métodos de utilizar los mismos | |
| CY1122803T1 (el) | Διαδικασιες γραμμης παραγωγης σπορων και χρησεις αυτων | |
| CY1126072T1 (el) | Περιοχες gla ως θεραπευτικοι παραγοντες | |
| CY1122314T1 (el) | Κυκλοπροπυλαμινες ως αναστολεις lsd1 | |
| MX2023015185A (es) | Degradadores de proteinas y usos de los mismos. | |
| GEAP202114720A (en) | Constructs having a sirp-alpha domain or variant thereof | |
| CY1122415T1 (el) | Κυκλοπροπυλαμινες ως lsd1 αναστολεις | |
| EP3806758C0 (en) | BIPOLAR MEDICAL INSTRUMENT | |
| CY1122227T1 (el) | Ρυθμιση δραστικοτητας συμπληρωματος | |
| EP3616156A4 (en) | PIG TISSUE TRACEABILITY | |
| BR112017024384A2 (pt) | bactérias modificadas para reduzir hiperfenilalaninemia | |
| CL2016002849A1 (es) | Oligómeros y conjugados de oligómeros | |
| BR112017012859A2 (pt) | fosforamidatos para o tratamento do vírus da hepatite b | |
| MX391501B (es) | Agentes inductores de apoptosis | |
| UY36304A (es) | Proteínas de fusión, bacterias recombinantes y métodos de uso de las bacterias recombinantes | |
| MX373045B (es) | Inhibidores de mdm2 y metodos terapeuticos que utilizan el mismo. | |
| EA201691978A1 (ru) | Соединения в качестве модуляторов ror гамма | |
| CY1125150T1 (el) | Ενωσεις φαινυλο-2-υδροξυ-ακετυλαμινο-2-μεθυλο-φαινυλιου | |
| LT3166628T (lt) | Terapinis kaulų morfogenetinių baltymų panaudojimas | |
| DK3999119T3 (da) | Modificerede AVV-capsidproteiner til behandling af slidgigtsygdom | |
| CO2020016105A2 (es) | Proteínas inmunodominantes y fragmentos en esclerosis múltiple | |
| MX2016014633A (es) | Nuevos derivados de cath2. | |
| IL280638A (en) | Fat tissue treatment | |
| CL2018000137S1 (es) | Implante dental | |
| EA201991927A1 (ru) | Новый иммуностимулирующий макролид |